Posts

Showing posts with the label Cocaine Use Disorder (CUD) competitive landscape

Cocaine Use Disorder (CUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Cocaine Use Disorder (CUD) Market Outlook Thelansis’s “Cocaine Use Disorder (CUD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Cocaine Use Disorder (CUD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market...

Cocaine Use Disorder (CUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

  Cocaine Use Disorder (CUD) Market Outlook Thelansis’s “Cocaine Use Disorder (CUD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Cocaine Use Disorder (CUD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Cocaine Use Disorder (CUD) Overview Cocaine use disorder (CUD) is a significant global public health issue characterized by the compulsive use of cocaine despite its detrimental medical, psychological, and behavioral effects. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), defines CUD as the presence of at least 2 out of 11 criteria causing clinically significant impairment or distress withi...

Cocaine Use Disorder (CUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Cocaine use disorder (CUD) is a significant global public health issue characterized by the compulsive use of cocaine despite its detrimental medical, psychological, and behavioral effects. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), defines CUD as the presence of at least 2 out of 11 criteria causing clinically significant impairment or distress within 12 months. These criteria can be categorized into four groups: physiological (craving, tolerance, and withdrawal), loss of control, prioritization of cocaine over other activities, and negative consequences resulting from cocaine use. The severity of CUD is determined by the number of symptoms present: mild CUD is indicated by two or three symptoms, moderate CUD by four or five symptoms, and severe CUD by six or more symptoms. Continued cocaine use over time carries a high risk of progressing to CUD, particularly among individuals who initiate cocaine use around the age of 20. This younger popu...